Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Insurance companies can no longer implement harmful co-pay accumulator policies.
A look at the supply chain that results in very high costs for HIV and hepatitis C medications.
The subscription-based model is the first of its kind.
Nearly 21 million Americans could lose coverage. Meanwhile, the GOP won’t offer a health care replacement until after 2020.
In fact, antiviral drugs account for nearly 14 percent of total drug costs in the program.
The patient advocacy coalition I Am Essential sent a letter to the HHS spelling out why the plan is dangerous.
Louisiana health officials are adopting the country’s first subscription model for hep C cures.
The American territory also does not cover liver transplants for sick people.
That’s according to an analysis of four large health systems from around the United States.
A new report by the National Viral Hepatitis Roundtable tracks the progress.
A national survey gauges HIV care providers’ views about the Affordable Care Act.
The drugs are set to come out in January 2019 with a list price of $24,000 for the most common dose for each.
New recommendations in the Annals of Internal Medicine would increase access to treatment.
The idea is being referred to as a “subscription-based” model.
It is one of 12 states that still limits medications to only the sickest patients.
The case alleged that the state’s Medicaid system was setting too many barriers for HCV-positive patients.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.